We are a commercial, non-profit, public sector company NMS develops and produces medical isotopes and radiopharmaceuticals for diagnostic use. We represent one of Norway’s largest investments in advanced medical research and diagnostics. We are owned by Oslo University Hospital (70%), University of Oslo (20%) and Akershus University Hospital (10%). Our profits are reinvested into research and development.